Method for external sterilization of drug delivery device

US12233177B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12233177-B2
Application numberUS-202017022695-A
CountryUS
Kind codeB2
Filing dateSep 16, 2020
Priority dateSep 16, 2019
Publication dateFeb 25, 2025
Grant dateFeb 25, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of externally sterilizing a drug delivery device utilizing Nitrogen Dioxide (NO2) is provided, including placing the drug delivery device in a sterilization chamber, introducing into the chamber a dose of NO2 having a concentration of between about 2 and 20 milligrams per Liter by applying a vacuum level of between about 10 and 600 Torr and holding the vacuum level for a dwell time of between about 2 and 20 minutes, repeating the step of introducing into the chamber a dose of NO2 for a number of pulses between about 1 and 24, purging the sterilization chamber of at least substantially all of the NO2, and aerating the sterilization chamber.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of externally sterilizing a drug delivery device utilizing Nitrogen Dioxide (NO2), comprising: placing the drug delivery device in a sterilization chamber, wherein the drug delivery device is a syringe comprising a barrel, a flange portion, and a backstop coupled with the flange portion; introducing into the sterilization chamber a dose of NO2 having a concentration of between about 2 and 20 milligrams per Liter by applying a vacuum level of between about 10 and 600 Torr and holding the vacuum level for a dwell time of between about 2 and 20 minutes, wherein the backstop is configured to permit or promote the NO2 to flow through a space between the backstop and the syringe when the backstop is coupled with the syringe; repeating the step of introducing into the sterilization chamber the dose of NO2 for a number of pulses between about 1 and 24; purging the sterilization chamber of at least substantially all of the NO2; and aerating the sterilization chamber. 2. A method as in claim 1 , wherein the syringe is a pre-filled syringe further comprising a stopper and a plunger rod, and wherein the barrel contains a medicament. 3. A method as in claim 2 , wherein the medicament is a VEGF antagonist. 4. A method as in claim 1 , wherein the barrel is a plastic barrel. 5. A method as in claim 1 , wherein the vacuum level is between about 100 and 500 Torr. 6. A method as in claim 1 , wherein the vacuum level is between about 150 and 400 Torr. 7. A method as in claim 1 , wherein the vacuum level is between about 150 and 300 Torr. 8. A method as in claim 1 , wherein the concentration of the dose of NO2 is between about 2 and 10 milligrams per Liter. 9. A method as in claim 1 , wherein the concentration of the dose of NO2 is between about 2 and 7 milligrams per Liter. 10. A method as in claim 1 , wherein the chamber has a relative humidity is between about 70 and 90 percent. 11. A method as in claim 1 , wherein the dwell time is between about 2 and 12 minutes. 12. A method as in claim 1 , wherein the dwell time is between about 2 and 7 minutes. 13. A method as in claim 1 , wherein the number of pulses is between about 1 and 12. 14. A method as in claim 1 , wherein the number of pulses is between about 1 and 8. 15. A method as in claim 1 , wherein the number of pulses is between about 1 and 4. 16. A method as in claim 1 , wherein the number of pulses is between about 1 and 2. 17. A method as in claim 1 , wherein the step of aerating the sterilization chamber includes aerating the sterilization chamber a number of cycles between about 12 and 70 cycles to at least substantially prevent discoloration of the drug delivery device. 18. A method as in claim 1 , wherein the method of externally sterilizing the drug delivery device achieves at least a 2 logs microbial reduction. 19. A method as in claim 1 , wherein the method of externally sterilizing the drug delivery device achieves at least a 3 logs microbial reduction. 20. A method as in claim 1 , wherein the method of externally sterilizing the drug delivery device achieves at least a 4 logs microbial reduction. 21. A method as in claim 1 , wherein the method of externally sterilizing the drug delivery device achieves at least a 5 logs microbial reduction. 22. A method as in claim 1 , wherein the method of externally sterilizing the drug delivery device achieves at least a 6 logs microbial reduction. 23. A method of externally sterilizing a drug delivery device utilizing Nitrogen Dioxide (NO2), comprising: placing the drug delivery device in a sterilization chamber, wherein the drug delivery device is a syringe comprising a barrel, a flange portion, and a backstop coupled with the flange portion; introducing into the sterilization chamber a dose of NO2 having a concentration of between about 5 and 20 milligrams per Liter by applying a vacuum level of between about 150 and 500 Torr and holding the vacuum level for a dwell time of between about 5 and 10 minutes, wherein the backstop is configured to permit or promote the NO2 to flow through a space between the backstop and the syringe when the backstop is coupled with the syringe; repeating the step of introducing into the sterilization chamber the dose of NO2 for a number of pulses between about 1 and 24; purging the sterilization chamber of at least substantially all of the NO2; and aerating the sterilization chamber a number of cycles between about 20 and 90. 24. A method of externally sterilizing a pre-filled syringe having a drug container and a medicament contained in the drug container, the method of externally sterilizing comprising the following steps: placing the pre-filled syringe in a sterilization chamber, the pre-filled syringe comprising a flange portion and a backstop coupled with the flange portion; introducing into the sterilization chamber a dose of Nitrogen Dioxide (NO2) having a predetermined concentration by applying a predetermined vacuum level and holding the vacuum level for a predetermined dwell time, wherein the backstop is configured to permit or promote the NO2 to flow through a space between the backstop and the pre-filled syringe when the backstop is coupled with the pre-filled syringe; repeating the step of e introducing into the sterilization chamber the dose of NO2 for a number of pulses between about 1 and 24; purging the sterilization chamber of at least substantially all of the NO2; and aerating the sterilization chamber a predetermined number of cycles, wherein the method of externally sterilizing the pre-filled syringe achieves at least a log 6 lethality target for the pre-filled syringe while realizing an ingress of NO2 gas into the drug container of less than 3.0 parts per million, as measured 30 days after externally sterilizing the pre-filled syringe.

Assignees

Inventors

Classifications

  • Laboratory, medical or dentistry appliances, e.g. catheters or sharps · CPC title

  • Living organisms or biological materials · CPC title

  • Chambers for sterilisation · CPC title

  • Accessories · CPC title

  • Specially designed finger grip means, e.g. for easy manipulation of the syringe rod · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12233177B2 cover?
A method of externally sterilizing a drug delivery device utilizing Nitrogen Dioxide (NO2) is provided, including placing the drug delivery device in a sterilization chamber, introducing into the chamber a dose of NO2 having a concentration of between about 2 and 20 milligrams per Liter by applying a vacuum level of between about 10 and 600 Torr and holding the vacuum level for a dwell time of …
Who is the assignee on this patent?
Amgen Inc
What technology area does this patent fall under?
Primary CPC classification A61M5/001. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).